monoclonal antibodies

Disc Medicine pays $10M upfront for monoclonal antibody for rare blood disorder, cancer
Endpoints
Fri, 01/20/23 - 10:46 am
Disc Mdedicine
Mabwell Therapeutics
monoclonal antibodies
Lilly's Covid-19 mAb no longer authorized due to Omicron subvariants, FDA says
Endpoints
Wed, 11/30/22 - 08:04 pm
Eli Lilly
FDA
COVID-19
Omicron
bebtelovimab
monoclonal antibodies
Kineta, Merck Strike Deal to Pair Anti-VISTA Antibody with Keytruda
BioSpace
Mon, 10/17/22 - 10:51 am
Kineta
Merck
Keytruda
anti-VISTA
monoclonal antibodies
solid tumors
Biogen’s Antibody Lupus Treatment Shows Mid-Stage Promise
BioSpace
Fri, 09/9/22 - 11:07 am
Biogen
litifilimab
lupus
systemic lupus erythematosus
monoclonal antibodies
clinical trials
Pursuing AbbVie and J&J, Innovent hits primary endpoint in phase 2 psoriasis trial
Fierce Biotech
Wed, 08/10/22 - 10:49 am
Innovent
AbbVie
JNJ
monoclonal antibodies
psoriasis
clinical trials
United BioPharma's Study Reveals New Class of Monoclonal Antibody for Effective Relief of Urticaria Symptoms
Drugs.com
Mon, 08/8/22 - 10:28 am
United BioPHarma
chronic spontaneous urticaria
clinical trials
monoclonal antibodies
UB-221
Roche, Genentech sign license deal with Kiniksa for vixarelimab
Pharmaceutical Business Review
Thu, 08/4/22 - 10:54 am
Kiniksa Pharmaceuticals
Roche
Genentech
vixarelimab
monoclonal antibodies
Survey puts spotlight on US neurologists’ response to CMS Alzheimer drugs decision
Biopharma Reporter
Mon, 05/16/22 - 10:48 am
Biogen
Aduhelm
monoclonal antibodies
CMS
Alzheimer's disease
neurologists
FDA cuts off use of GSK's Covid treatment in almost half of the US as BA.2 spreads
Endpoints
Mon, 04/4/22 - 10:21 am
FDA
GSK
Vir Biotechnology
monoclonal antibodies
COVID-19
Omicron BA.2
Officials limit an antibody therapy, saying it’s ineffective against BA.2 variant of Omicron
Stat
Sun, 03/27/22 - 04:00 pm
Vir Biotechnology
GSK
monoclonal antibodies
sotrovimab
COVID-19
Omicron BA.2
FDA
In year 3 of the pandemic, a new Covid-19 biotech takes flight with an antibody combo and Takeda's ex-vaccines chief at the helm
Endpoints
Tue, 03/22/22 - 10:12 am
COVID-19
Aerium Therapeutics
monoclonal antibodies
Omega Funds
Resistance mutations found in those receiving GSK and Vir’s monoclonal for Delta, new research shows
Endpoints
Fri, 03/11/22 - 10:43 am
COVID-19
GSK
Vir
monoclonal antibodies
AstraZeneca and Neurimmune close agreement to develop monoclonal antibody, NI006
Biopharma Reporter
Tue, 03/1/22 - 10:23 am
Alexion
AstraZeneca
Neurimmune
N!006
monoclonal antibodies
transthyretin amyloid cardiomyopathy
Biogen and Xbrane in deal on rheumatoid arthritis targeting biosimilar
Biopharma Reporter
Mon, 02/14/22 - 11:04 am
Biogen
Xbrane Biopharma
monoclonal antibodies
Xcimzane
Cimzia
rheumatoid arthritis
Lilly back in COVID-19 antibody game with $720 million deal with U.S. for omicron-busting hopeful
Fierce Pharma
Fri, 02/11/22 - 11:48 am
Eli Lilly
monoclonal antibodies
COVID-19
bebtelovimab
FDA approves Sanofi's monoclonal antibody treatment for CAD
Biopharma Reporter
Mon, 02/7/22 - 10:29 am
Sanofi
cold agglutinin disease
FDA
monoclonal antibodies
Enjaymo
‘There’s no free lunch with drugs’: Janet Woodcock talks Covid monoclonal antibodies and pediatric vaccines
Stat
Fri, 01/28/22 - 10:16 am
FDA
monoclonal antibodies
Janet Woodcock
vaccines
COVID-19
Hospitals use a lottery to allocate scarce COVID drugs for the immunocompromised
NPR
Tue, 01/25/22 - 11:39 pm
lottery
COVID-19
monoclonal antibodies
patients
immunocompromised patients
Lilly's Phase 3 Study Of Lebrikizumab In Atopic Dermatitis Meets All Goals
NASDAQ
Tue, 12/21/21 - 10:30 am
Eli Lilly
lebrikizumab
monoclonal antibodies
atopic dermatitis
clinical trials
US pauses distribution of GSK/Vir's Covid mAb not due to Omicron, but greater supply of Eli Lilly mAbs
Endpoints
Wed, 12/15/21 - 10:42 am
GSK
Vir Biotechnology
Eli Lilly
monoclonal antibodies
COVID-19

Pages